Hypertrophic Cardiomyopathy: For Heart Failure Clinics: Genetics of Cardiomyopathy and Heart Failure

作者: Carolyn Y. Ho

DOI: 10.1016/J.HFC.2009.12.001

关键词:

摘要: Important insights into the molecular basis of hypertrophic cardiomyopathy (HCM) and related diseases have been gained by studying families with inherited cardiac hypertrophy. Integrated clinical genetic investigations demonstrated that different defects can give rise to common phenotype Diverse pathways identified, implicating perturbations in force generation, transmission, intracellular calcium homeostasis, myocardial energetics, metabolism causing disease. Although not fully elucidated, fundamental mechanisms linking gene mutations disease are being characterized. Further advances will allow a better understanding pathogenesis, diagnosis, treatment, just relatively rare cardiomyopathies, but also be relevance more acquired forms remodeling.

参考文章(74)
Barbara Bauce, Alessandra Rampazzo, Cristina Basso, Alessia Bagattin, Luciano Daliento, Natascia Tiso, Pietro Turrini, Gaetano Thiene, Gian Antonio Danieli, Andrea Nava, Screening for ryanodine receptor type 2 mutations in families with effort-induced polymorphic ventricular arrhythmias and sudden death: early diagnosis of asymptomatic carriers Journal of the American College of Cardiology. ,vol. 40, pp. 341- 349 ,(2002) , 10.1016/S0735-1097(02)01946-0
Kimberly A. Palmiter, Matthew J. Tyska, Joe R. Haeberle, Norman R. Alpert, Lameh Fananapazir, David M. Warshaw, R403Q and L908V mutant β-cardiac myosin from patients with familial hypertrophic cardiomyopathy exhibit enhanced mechanical performance at the single molecule level Journal of Muscle Research and Cell Motility. ,vol. 21, pp. 609- 620 ,(2000) , 10.1023/A:1005678905119
Elena Biagini, Fabio Coccolo, Marinella Ferlito, Enrica Perugini, Guido Rocchi, Letizia Bacchi-Reggiani, Carla Lofiego, Giuseppe Boriani, Daniela Prandstraller, Fernando M. Picchio, Angelo Branzi, Claudio Rapezzi, Dilated-Hypokinetic Evolution of Hypertrophic Cardiomyopathy: Prevalence, Incidence, Risk Factors, and Prognostic Implications in Pediatric and Adult Patients Journal of the American College of Cardiology. ,vol. 46, pp. 1543- 1550 ,(2005) , 10.1016/J.JACC.2005.04.062
Dimitrios Georgakopoulos, Michael E. Christe, Michael Giewat, Christine M. Seidman, J.G. Seidman, David A. Kass, The pathogenesis of familial hypertrophic cardiomyopathy: Early and evolving effects from an α-cardiac myosin heavy chain missense mutation Nature Medicine. ,vol. 5, pp. 327- 330 ,(1999) , 10.1038/6549
Sara L. Van Driest, Erik G. Ellsworth, Steve R. Ommen, A. Jamil Tajik, Bernard J. Gersh, Michael J. Ackerman, Prevalence and spectrum of thin filament mutations in an outpatient referral population with hypertrophic cardiomyopathy. Circulation. ,vol. 108, pp. 445- 451 ,(2003) , 10.1161/01.CIR.0000080896.52003.DF
A.J. Marian, R. Roberts, The Molecular Genetic Basis for Hypertrophic Cardiomyopathy Journal of Molecular and Cellular Cardiology. ,vol. 33, pp. 655- 670 ,(2001) , 10.1006/JMCC.2001.1340
M Spindler, K W Saupe, M E Christe, H L Sweeney, C E Seidman, J G Seidman, J S Ingwall, Diastolic dysfunction and altered energetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy. Journal of Clinical Investigation. ,vol. 101, pp. 1775- 1783 ,(1998) , 10.1172/JCI1940
Dirk Westermann, Björn C. Knollmann, Paul Steendijk, Susanne Rutschow, Alexander Riad, Matthias Pauschinger, James D. Potter, Heinz-Peter Schultheiss, Carsten Tschöpe, Diltiazem treatment prevents diastolic heart failure in mice with familial hypertrophic cardiomyopathy European Journal of Heart Failure. ,vol. 8, pp. 115- 121 ,(2006) , 10.1016/J.EJHEART.2005.07.012